Fennec Pharmaceuticals (FENC) Share-based Compensation (2010 - 2025)
Fennec Pharmaceuticals posted quarterly Share-based Compensation of $2.5 million for Q4 2025, up 124.38% year-on-year from $1.1 million in Q4 2024, and up 13.65% on a QoQ basis from $2.2 million in Q3 2025.
Fennec Pharmaceuticals (FENC) has 16 years of Share-based Compensation data on file, last reported at $2.5 million in Q4 2025.
- For the quarter ending Q4 2025, Share-based Compensation rose 124.38% year-over-year to $2.5 million; the trailing twelve-month figure through Dec 2025 stood at $7.0 million (up 38.96% YoY), and the FY2025 full-year result was $7.0 million, up 38.96% from the prior year.
- Share-based Compensation for Q4 2025 stood at $2.5 million, up from $2.2 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $3.7 million in Q4 2021 and bottomed at $30000.0 in Q4 2022.
- The 5-year median for Share-based Compensation is $1.0 million (2023), against an average of $1.2 million.
- The widest annual swing landed in 2021, when Share-based Compensation surged 17709.52%; it then sank 99.2% in 2022.
- A 5-year view of Share-based Compensation shows it stood at $3.7 million in 2021, then tumbled by 99.2% to $30000.0 in 2022, then soared by 2756.67% to $857000.0 in 2023, then soared by 31.16% to $1.1 million in 2024, then surged by 124.38% to $2.5 million in 2025.
- The last three Share-based Compensation figures came in at $2.5 million (Q4 2025), $2.2 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 2.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.52 Mn |
| Dec 31, 2025 | 2.52 Mn |
| Sep 30, 2025 | 2.22 Mn |
| Sep 30, 2025 | 2.22 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Mar 31, 2025 | 798,000.00 |
| Mar 31, 2025 | 798,000.00 |
| Dec 31, 2024 | 1.12 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.82 Mn |
| Sep 30, 2024 | 1.82 Mn |
| Jun 30, 2024 | 925,000.00 |
| Jun 30, 2024 | 925,000.00 |
| Mar 31, 2024 | 1.19 Mn |
| Mar 31, 2024 | 1.19 Mn |
| Dec 31, 2023 | 857,000.00 |
| Dec 31, 2023 | 857,000.00 |
| Sep 30, 2023 | 865,000.00 |
| Sep 30, 2023 | 865,000.00 |
| Jun 30, 2023 | 2.54 Mn |
| Jun 30, 2023 | 2.54 Mn |
| Mar 31, 2023 | 1.09 Mn |
| Mar 31, 2023 | 1.09 Mn |
| Dec 31, 2022 | 30,000.00 |
| Dec 31, 2022 | 30,000.00 |
| Sep 30, 2022 | 34,000.00 |
| Sep 30, 2022 | 34,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Mar 31, 2022 | 34,000.00 |
| Mar 31, 2022 | 34,000.00 |
| Dec 31, 2021 | 3.74 Mn |
| Dec 31, 2021 | 3.74 Mn |
| Sep 30, 2021 | 917,000.00 |
| Sep 30, 2021 | 917,000.00 |
| Jun 30, 2021 | 1.33 Mn |
| Jun 30, 2021 | 1.33 Mn |
| Mar 31, 2021 | 587,000.00 |
| Mar 31, 2021 | 587,000.00 |
| Dec 31, 2020 | 21,000.00 |
| Dec 31, 2020 | 21,000.00 |
| Sep 30, 2020 | 1.24 Mn |
| Sep 30, 2020 | 1.24 Mn |
| Jun 30, 2020 | 21,000.00 |
| Jun 30, 2020 | 21,000.00 |
| Mar 31, 2020 | 391,000.00 |
| Mar 31, 2020 | 391,000.00 |
| Dec 31, 2019 | -195,000.00 |
| Dec 31, 2019 | -195,000.00 |
| Sep 30, 2019 | 21,000.00 |
| Sep 30, 2019 | 21,000.00 |
| Jun 30, 2019 | 331,000.00 |
| Jun 30, 2019 | 331,000.00 |
| Mar 31, 2019 | 221,000.00 |
| Mar 31, 2019 | 221,000.00 |
| Dec 31, 2018 | 1.58 Mn |
| Dec 31, 2018 | 1.58 Mn |
| Sep 30, 2018 | 46,000.00 |
| Sep 30, 2018 | 46,000.00 |
| Jun 30, 2018 | 83,000.00 |
| Jun 30, 2018 | 83,000.00 |
| Mar 31, 2018 | 174,000.00 |
| Mar 31, 2018 | 174,000.00 |
| Dec 31, 2017 | 965,000.00 |
| Dec 31, 2017 | 965,000.00 |
| Sep 30, 2017 | 907,000.00 |
| Sep 30, 2017 | 907,000.00 |
| Jun 30, 2017 | 286,000.00 |
| Jun 30, 2017 | 286,000.00 |
| Mar 31, 2017 | 56,000.00 |
| Mar 31, 2017 | 56,000.00 |
| Dec 31, 2016 | -64,000.00 |
| Dec 31, 2016 | -64,000.00 |
| Sep 30, 2016 | 28,000.00 |
| Sep 30, 2016 | 28,000.00 |
| Jun 30, 2016 | 17,000.00 |
| Jun 30, 2016 | 17,000.00 |
| Dec 31, 2015 | 88,000.00 |
| Dec 31, 2015 | 88,000.00 |
| Mar 31, 2015 | 9,000.00 |
| Mar 31, 2015 | 9,000.00 |
| Dec 31, 2014 | 183,000.00 |
| Dec 31, 2014 | 183,000.00 |
| Sep 30, 2014 | 122,000.00 |
| Sep 30, 2014 | 122,000.00 |
| Mar 31, 2014 | 129,000.00 |
| Mar 31, 2014 | 129,000.00 |
| Dec 31, 2013 | -35,000.00 |
| Dec 31, 2013 | -35,000.00 |
| Sep 30, 2013 | 41,000.00 |
| Sep 30, 2013 | 41,000.00 |
| Jun 30, 2013 | 29,000.00 |
| Jun 30, 2013 | 29,000.00 |
| Dec 31, 2012 | 136,000.00 |
| Dec 31, 2012 | 136,000.00 |
| Jun 30, 2012 | 17,000.00 |
| Jun 30, 2012 | 17,000.00 |
| Sep 30, 2011 | 129,000.00 |
| Sep 30, 2011 | 129,000.00 |
| Jun 30, 2011 | 49,000.00 |
| Jun 30, 2011 | 49,000.00 |
| Sep 30, 2010 | 386,000.00 |
| Sep 30, 2010 | 386,000.00 |
| Jun 30, 2010 | 2.05 Mn |
| Jun 30, 2010 | 2.05 Mn |